About KPL
KPL is a company based in Gaithersburg (United States) founded in 1979 was acquired by SeraCare in August 2013. KPL offers products and services including NGS Solutions, Controls & Reference Materials, and Immunoassay Reagents. KPL operates in a competitive market with competitors including GenScript, Sino Biological, Epitomics, Y-Biologics and Mabtech, among others.
- Headquarter Gaithersburg, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of KPL
KPL offers a comprehensive portfolio of products and services, including NGS Solutions, Controls & Reference Materials, and Immunoassay Reagents.
Reference standards for next-generation sequencing in diagnostics.
Materials for validating and monitoring assay performance.
Reagents to support research and IVD assay development.
Funding Insights of KPL
Detailed funding history for KPL
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in KPL
KPL has secured backing from 1 investor. Prominent investors backing the company include SeraCare.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Provider of biological materials/products that help optimize diagnostic performance, reliability and repeatability
|
Locked | Locked | Locked |
Investor details for KPL
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by KPL
Investment portfolio details for KPL
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - KPL
Detailed financials for KPL
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Kpl Comparisons
Peer comparison for KPL
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of KPL
KPL operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GenScript, Sino Biological, Epitomics, Y-Biologics and Mabtech, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Reagents and instruments are provided for life sciences research.
|
|
| Locked | Locked | Locked |
Reagents and kits are provided for clinical research applications.
|
|
| Locked | Locked | Locked |
Monoclonal antibody technology and products are developed by Epitomics.
|
|
| Locked | Locked | Locked |
Developer of antibodies for the treatment of multiple diseases
|
|
| Locked | Locked | Locked |
Antibodies and immunoassay kits are developed for research applications.
|
|
| Locked | Locked | Locked |
Labeling and detection reagents immunohistochemistry studies and other life science research applications
|
Detailed competitors of KPL
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Kpl
Complete news archive for KPL
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about KPL
KPL was founded in 1979.
KPL is headquartered in Gaithersburg, United States. It is registered at Gaithersburg, Maryland, United States.
As of Aug 19, 2013 KPL operates as a subsidiary of Seracare Life Sciences. KPL develops, manufactures, and markets high quality immunochemicals for life science and in vitro diagnostics. KPL was claims to be the first company to commercialize affinity purified secondary antibodies, a valuable tool for biological research and in vitro diagnostic testing. Since then KPL has introduced over 800 reagents and complete assay kits for protein visualization and nucleic acid detection that address the needs of cell biology, immunology, protein chemistry, and molecular biology scientists. SeraCares portfolio of KPL products includes primary and secondary antibodies as well as reagents and kits targeting ELISA, western blotting, immunohistology, protein labeling, nucleic acid labeling, sample preparation, protein purification, and recombinant protein detection and analysis.
KPL's top competitors include Sino Biological, GenScript and Y-Biologics.
KPL offers NGS Solutions, Controls & Reference Materials, and Immunoassay Reagents.
KPL has 1 investor. Key investors include SeraCare.